MarketLens
Sign Up

What Triggered uniQure's Sudden Stock Plunge

5 months ago
SHARE THIS ON:

What Triggered uniQure's Sudden Stock Plunge

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Related Articles

Category

You may also like

Stock News3 weeks ago

uniQure (QURE) Reports Q2 Loss, Misses Revenue Estimates

uniQure (QURE) reported a Q2 loss of $1.22 per share, wider than the $0.81 consensus estimate and the $0.69 loss a year ago, as revenue missed expectations.
Stock News3 weeks ago

Capricor Therapeutics Stock Plunges After FDA Releases Briefing Documents

Capricor Therapeutics shares fell over 60% Monday after the FDA released briefing documents ahead of the July 29 advisory committee meeting.
Stock News1 months ago

uniQure Trends to Watch as Gene Therapy Bets Shift Beyond Hemgenix

uniQure is shifting gene therapy focus beyond Hemgenix toward CNS pipeline expansion, with AMT-130 as the centerpiece, supported by faster regulatory pathways and a streamlined business model.
Stock News3 months ago

Why GeneDX Stock Is Plummeting Today

GeneDX shares fell sharply following the release of its latest quarterly report. The decline reflects investor disappointment with the company's financial results and operational updates provided in t...

Breaking News

View All →

Top Headlines

View More →
Stock News2 hours ago

3 Buy-Rated Dividend Stocks to Play the AI Boom

Stock News2 hours ago

Walmart Adds to Wall Street Pressures With Weak Sales Growth

Stock News2 hours ago

Amazon drone makes a splash after dropping a package in a Texas woman's pool: 'We're living in the Jetsons era'

Stock News2 hours ago

What Went Wrong With Walmart?

Stock News2 hours ago

Goldman Sachs Just Paid $2.25 Billion for the Family Behind Your 14% Income Fund